US biotechnology firm Moderna has announced its coronavirus vaccine is more than 94% effective at preventing the disease. Interim data from the US firm Moderna suggests its vaccine is highly effective in preventing people getting ill and also works across all age groups, including the elderly. After the second dose they included fatigue, myalgia (muscle pain), arthralgia (joint pain), headache, pain, and redness at the injection site. Stephane Bancel, chief executive officer of Moderna, said: “This is a pivotal moment in the development of our Covid-19 vaccine candidate. Russian trials last week also reported that a vaccine candidate was 92% effective, with results set to be peer-reviewed soon.

Source: Huffington Post November 16, 2020 12:21 UTC